| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 1.92e-07 | 44 | 119 | 6 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 3.71e-07 | 49 | 119 | 6 | GO:0050685 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.69e-06 | 63 | 119 | 6 | GO:0033120 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 2.72e-05 | 207 | 119 | 8 | GO:0043484 | |
| GeneOntologyCellularComponent | spliceosomal complex | PTBP2 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E SART1 PRPF3 RBMY1F | 4.25e-06 | 215 | 120 | 9 | GO:0005681 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CPSF4L ERCC6 PTBP2 NELFA RBMY1A1 RBMY1C HMGXB4 RBMY1D RBMY1B RBMY1E ATF2 SART1 PCGF6 POLR3D PRPF3 NFKB1 RBMY1F UBE2S CPSF2 XRCC6 | 1.08e-04 | 1377 | 120 | 20 | GO:0140513 |
| GeneOntologyCellularComponent | male germ cell nucleus | 1.38e-04 | 86 | 120 | 5 | GO:0001673 | |
| GeneOntologyCellularComponent | germ cell nucleus | 4.91e-04 | 113 | 120 | 5 | GO:0043073 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 7.03e-04 | 185 | 120 | 6 | GO:0009898 | |
| Domain | RBM1CTR | 4.88e-10 | 8 | 117 | 5 | PF08081 | |
| Domain | RBM1CTR | 4.88e-10 | 8 | 117 | 5 | IPR012604 | |
| Domain | RRM_1 | 4.99e-05 | 208 | 117 | 8 | PF00076 | |
| Domain | RRM | 6.73e-05 | 217 | 117 | 8 | SM00360 | |
| Domain | RRM_dom | 9.21e-05 | 227 | 117 | 8 | IPR000504 | |
| Domain | RRM | 1.01e-04 | 230 | 117 | 8 | PS50102 | |
| Domain | Ryanodine_rcpt | 1.16e-04 | 3 | 117 | 2 | IPR003032 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 1.16e-04 | 3 | 117 | 2 | IPR006794 | |
| Domain | Zfx_Zfy_act | 1.16e-04 | 3 | 117 | 2 | PF04704 | |
| Domain | Ryanrecept_TM4-6 | 1.16e-04 | 3 | 117 | 2 | IPR009460 | |
| Domain | RyR | 1.16e-04 | 3 | 117 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.16e-04 | 3 | 117 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.16e-04 | 3 | 117 | 2 | IPR013333 | |
| Domain | Nucleotide-bd_a/b_plait | 2.22e-04 | 258 | 117 | 8 | IPR012677 | |
| Domain | PXA | 2.32e-04 | 4 | 117 | 2 | SM00313 | |
| Domain | PXA | 2.32e-04 | 4 | 117 | 2 | PS51207 | |
| Domain | PXA | 2.32e-04 | 4 | 117 | 2 | PF02194 | |
| Domain | Sorting_nexin_C | 2.32e-04 | 4 | 117 | 2 | IPR013937 | |
| Domain | Phox_assoc | 2.32e-04 | 4 | 117 | 2 | IPR003114 | |
| Domain | Nexin_C | 2.32e-04 | 4 | 117 | 2 | PF08628 | |
| Domain | - | 3.84e-04 | 5 | 117 | 2 | 2.40.290.10 | |
| Domain | SPOC-like_C_dom | 3.84e-04 | 5 | 117 | 2 | IPR016194 | |
| Domain | RIH_assoc-dom | 5.74e-04 | 6 | 117 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 5.74e-04 | 6 | 117 | 2 | PF08709 | |
| Domain | EFhand_Ca_insen | 5.74e-04 | 6 | 117 | 2 | PF08726 | |
| Domain | RIH_assoc | 5.74e-04 | 6 | 117 | 2 | PF08454 | |
| Domain | RIH_dom | 5.74e-04 | 6 | 117 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.74e-04 | 6 | 117 | 2 | IPR014821 | |
| Domain | EF-hand_Ca_insen | 5.74e-04 | 6 | 117 | 2 | IPR014837 | |
| Domain | Ryanodine_recept-rel | 5.74e-04 | 6 | 117 | 2 | IPR015925 | |
| Domain | - | 5.74e-04 | 6 | 117 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 5.74e-04 | 6 | 117 | 2 | PF01365 | |
| Domain | ANION_EXCHANGER_2 | 8.00e-04 | 7 | 117 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 8.00e-04 | 7 | 117 | 2 | PS00219 | |
| Domain | - | 8.74e-04 | 244 | 117 | 7 | 3.30.70.330 | |
| Domain | - | 1.36e-03 | 9 | 117 | 2 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 1.36e-03 | 9 | 117 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 1.36e-03 | 9 | 117 | 2 | PF07565 | |
| Domain | MIR | 1.69e-03 | 10 | 117 | 2 | PF02815 | |
| Domain | MIR_motif | 1.69e-03 | 10 | 117 | 2 | IPR016093 | |
| Domain | PTrfase/Anion_transptr | 1.69e-03 | 10 | 117 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.69e-03 | 10 | 117 | 2 | IPR003020 | |
| Domain | MIR | 1.69e-03 | 10 | 117 | 2 | PS50919 | |
| Domain | MIR | 1.69e-03 | 10 | 117 | 2 | SM00472 | |
| Domain | HCO3_cotransp | 1.69e-03 | 10 | 117 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.69e-03 | 10 | 117 | 2 | IPR011531 | |
| Domain | EF-hand_1 | 2.70e-03 | 152 | 117 | 5 | PF00036 | |
| Domain | SH2 | 5.07e-03 | 110 | 117 | 4 | SM00252 | |
| Domain | SH2 | 5.24e-03 | 111 | 117 | 4 | PS50001 | |
| Domain | SH2 | 5.40e-03 | 112 | 117 | 4 | IPR000980 | |
| Domain | - | 5.40e-03 | 112 | 117 | 4 | 3.30.505.10 | |
| Domain | aa-tRNA-synth_I_CS | 5.58e-03 | 18 | 117 | 2 | IPR001412 | |
| Domain | BRCT | 6.21e-03 | 19 | 117 | 2 | PF00533 | |
| Domain | AA_TRNA_LIGASE_I | 6.21e-03 | 19 | 117 | 2 | PS00178 | |
| Pathway | SA_B_CELL_RECEPTOR_COMPLEXES | 1.14e-05 | 24 | 84 | 4 | M17200 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 2.38e-05 | 10 | 84 | 3 | MM15624 | |
| Pathway | WP_IL5_SIGNALING_PATHWAY | 5.17e-05 | 68 | 84 | 5 | MM15930 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 7.09e-05 | 14 | 84 | 3 | M27908 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.31e-04 | 17 | 84 | 3 | MM15584 | |
| Pathway | BIOCARTA_41BB_PATHWAY | 1.56e-04 | 18 | 84 | 3 | M2064 | |
| Pathway | BIOCARTA_41BB_PATHWAY | 1.56e-04 | 18 | 84 | 3 | MM1511 | |
| Pubmed | 1.21e-14 | 7 | 123 | 6 | 8269511 | ||
| Pubmed | 1.57e-12 | 12 | 123 | 6 | 9598316 | ||
| Pubmed | 3.05e-12 | 6 | 123 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 1.06e-11 | 7 | 123 | 5 | 8875892 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | GTPBP4 ERCC6 IARS1 SMCHD1 GART RFC1 TRIP12 SEPTIN2 SART1 HARS2 PRPF3 CSNK1D CSNK1E AHNAK MDC1 SERPINE1 MKI67 ANKRD17 LYN QARS1 SPEN RPL7 XRCC6 NOL8 | 1.36e-11 | 1257 | 123 | 24 | 36526897 |
| Pubmed | 2.83e-11 | 8 | 123 | 5 | 7479793 | ||
| Pubmed | 1.27e-10 | 10 | 123 | 5 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 3.96e-10 | 12 | 123 | 5 | 20543856 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | SMCHD1 RFC1 TRIP12 SEPTIN2 ZNF711 SART1 PRPF3 MDC1 MKI67 SPEN XRCC6 NOL8 | 4.30e-10 | 283 | 123 | 12 | 30585729 |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 7.43e-10 | 5 | 123 | 4 | 8817321 | |
| Pubmed | 7.43e-10 | 5 | 123 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 7.43e-10 | 5 | 123 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 7.43e-10 | 5 | 123 | 4 | 19737860 | |
| Pubmed | GTPBP4 SMCHD1 GART RFC1 TRIP12 SART1 USP5 PREP AHNAK MDC1 MKI67 ANKRD17 HELZ SPEN RPL7 XRCC6 | 1.47e-09 | 653 | 123 | 16 | 22586326 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 1.49e-09 | 15 | 123 | 5 | 14762062 | |
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 2.22e-09 | 6 | 123 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 2.22e-09 | 6 | 123 | 4 | 12356914 | |
| Pubmed | 2.22e-09 | 6 | 123 | 4 | 9499427 | ||
| Pubmed | 2.22e-09 | 6 | 123 | 4 | 18239052 | ||
| Pubmed | 2.22e-09 | 6 | 123 | 4 | 15051956 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | STRN3 NELFA RFC1 TRIP12 ATF2 C2CD5 SART1 USP42 CSNK1E MDC1 MKI67 ANKRD17 HELZ CPSF2 PARD3 SPEN XRCC6 | 2.24e-09 | 774 | 123 | 17 | 15302935 |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 4.21e-09 | 18 | 123 | 5 | 12023983 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GTPBP4 ERCC6 PTBP2 SMCHD1 HMGXB4 RFC1 TRIP12 ZNF711 PCGF6 MDC1 MKI67 MASTL SPEN XRCC6 CUX1 | 4.53e-09 | 608 | 123 | 15 | 36089195 |
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 5.17e-09 | 7 | 123 | 4 | 10377282 | |
| Pubmed | 5.17e-09 | 7 | 123 | 4 | 17001072 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GTPBP4 ERCC6 WASHC4 RNF31 IARS1 SMCHD1 GART RFC1 TRIP12 SART1 PCGF6 USP5 PRPF3 AHNAK MDC1 MKI67 ANKRD17 PARD3 QARS1 RPL7 XRCC6 | 1.18e-08 | 1353 | 123 | 21 | 29467282 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | IARS1 SMCHD1 RFC1 TRIP12 SART1 PRPF3 AHNAK MDC1 CPSF2 QARS1 XRCC6 CUX1 | 1.76e-08 | 394 | 123 | 12 | 27248496 |
| Pubmed | 3.08e-08 | 10 | 123 | 4 | 10601091 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 3.41e-08 | 90 | 123 | 7 | 35654790 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 4.88e-08 | 203 | 123 | 9 | 22083510 | |
| Pubmed | GTPBP4 ERCC6 WASHC4 IARS1 RFC1 TRIP12 ZFY SART1 PRPF3 MDC1 MKI67 ANKRD17 QARS1 RPL7 CUX1 NOL8 | 5.57e-08 | 847 | 123 | 16 | 35850772 | |
| Pubmed | GTPBP4 ERCC6 DCDC1 RNF31 HMGXB4 ABCA8 C2CD5 SLC4A1 ZNF711 SART1 PRPF3 GLI3 MTR LRP4 ANKRD17 HELZ PARD3 VAV1 | 8.32e-08 | 1116 | 123 | 18 | 31753913 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 1.04e-07 | 13 | 123 | 4 | 23816659 | |
| Pubmed | 1.04e-07 | 13 | 123 | 4 | 10749975 | ||
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 1.45e-07 | 14 | 123 | 4 | 14611631 | |
| Pubmed | GTPBP4 IKZF3 IARS1 SMCHD1 HMGXB4 RFC1 PCGF6 GLI3 NFKB1 MDC1 CCDC138 MKI67 MTR ANKRD17 HELZ CPSF2 QARS1 SPEN XRCC6 CUX1 | 1.47e-07 | 1429 | 123 | 20 | 35140242 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | GTPBP4 SMCHD1 HMGXB4 RFC1 TRIP12 ATF2 SART1 PCGF6 USP42 PRPF3 AHNAK MDC1 MKI67 CPSF2 SPEN RPL7 XRCC6 CUX1 NOL8 | 1.50e-07 | 1294 | 123 | 19 | 30804502 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GTPBP4 STRN3 SMCHD1 GART RFC1 SEPTIN2 PRPF3 AHNAK MKI67 MASTL ANKRD17 HELZ LRBA RPL7 XRCC6 NOL8 | 2.09e-07 | 934 | 123 | 16 | 33916271 |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 3.42e-07 | 17 | 123 | 4 | 28115466 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | GTPBP4 ERCC6 SMCHD1 RFC1 TRIP12 MAP3K1 SART1 PRPF3 CSNK1E MKI67 QARS1 RPL7 XRCC6 NOL8 | 5.32e-07 | 759 | 123 | 14 | 35915203 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.63e-07 | 271 | 123 | 9 | 32433965 | |
| Pubmed | GTPBP4 ATG7 NELFA SMCHD1 RFC1 SART1 USP5 POLR3D PRPF3 AHNAK MDC1 MKI67 UBE2S CPSF2 MYO15A XRCC6 | 6.21e-07 | 1014 | 123 | 16 | 32416067 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 6.31e-07 | 358 | 123 | 10 | 32460013 | |
| Pubmed | GTPBP4 SMCHD1 GART TRIP12 SEPTIN2 SART1 PRPF3 AHNAK MDC1 MKI67 SSH2 LYN XRCC6 | 6.70e-07 | 660 | 123 | 13 | 32780723 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GTPBP4 IARS1 SMCHD1 GART TRIP12 SART1 PRPF3 AHNAK MDC1 MKI67 CPSF2 LYN QARS1 SPEN RPL7 XRCC6 | 7.06e-07 | 1024 | 123 | 16 | 24711643 |
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 8.57e-07 | 6 | 123 | 3 | 26025922 | |
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 27742708 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PTBP2 SMCHD1 HMGXB4 RFC1 TRIP12 ZNF711 SART1 PRPF3 AHNAK MDC1 MKI67 SPEN XRCC6 CUX1 NOL8 | 1.50e-06 | 954 | 123 | 15 | 36373674 |
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.54e-06 | 55 | 123 | 5 | 19468303 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | GTPBP4 IARS1 RFC1 SART1 PRPF3 MDC1 MKI67 CPSF2 SPEN RPL7 XRCC6 CUX1 | 1.72e-06 | 605 | 123 | 12 | 28977666 |
| Pubmed | 2.10e-06 | 26 | 123 | 4 | 35920200 | ||
| Pubmed | 2.21e-06 | 106 | 123 | 6 | 19394292 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | GTPBP4 NELFA SMCHD1 HMGXB4 RFC1 TRIP12 ZFY ZNF711 PCNX4 MDC1 MKI67 | 3.25e-06 | 533 | 123 | 11 | 30554943 |
| Pubmed | 3.57e-06 | 9 | 123 | 3 | 36764294 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | GTPBP4 IARS1 SMCHD1 GART RFC1 TRIP12 USP42 AHNAK MKI67 UBE2S HELZ LRBA CPSF2 LYN QARS1 RPL7 XRCC6 | 4.16e-06 | 1318 | 123 | 17 | 30463901 |
| Pubmed | Comparative mapping in the beige-satin region of mouse chromosome 13. | 5.09e-06 | 10 | 123 | 3 | 9027500 | |
| Pubmed | 6.90e-06 | 129 | 123 | 6 | 23022380 | ||
| Pubmed | CRYBG2 SMCHD1 RFC1 ZNF831 TRIP12 USP42 CSNK1D AHNAK NFKB1 SPEN | 6.97e-06 | 469 | 123 | 10 | 27634302 | |
| Pubmed | Gli3 is required for maintenance and fate specification of cortical progenitors. | 6.98e-06 | 11 | 123 | 3 | 21525285 | |
| Pubmed | Notch Activation by Shootin1 Opposing Activities on 2 Ubiquitin Ligases. | 6.98e-06 | 11 | 123 | 3 | 28981589 | |
| Pubmed | GTPBP4 SMCHD1 ACTN3 RFC1 TRIP12 MAP3K1 HARS2 CSNK1D AHNAK SERPINE1 MKI67 ANKRD17 CPSF2 PARD3 QARS1 RPL7 XRCC6 | 6.99e-06 | 1371 | 123 | 17 | 36244648 | |
| Pubmed | PTBP2 RTN4IP1 TRIP12 ATF2 SLC1A3 C2CD5 ZNF600 POLR3D CNOT6L CSNK1E MASTL ANKRD17 CPSF2 PARD3 LRRC71 | 7.02e-06 | 1084 | 123 | 15 | 11544199 | |
| Pubmed | GTPBP4 IARS1 GART RFC1 TRIP12 SART1 CSNK1D CSNK1E MKI67 ANKRD17 PARD3 LYN QARS1 RPL7 XRCC6 CUX1 | 8.74e-06 | 1247 | 123 | 16 | 27684187 | |
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 8.99e-06 | 37 | 123 | 4 | 36835656 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | GTPBP4 PTBP2 IARS1 PGK2 SEPTIN2 SART1 HARS2 USP5 ANKRD17 QARS1 RPL3L RPL7 XRCC6 | 1.01e-05 | 847 | 123 | 13 | 35235311 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | IARS1 TRIP12 SEPTIN2 SART1 PCGF6 AHNAK MKI67 ANKRD17 HELZ QARS1 SPEN NOL8 | 1.06e-05 | 724 | 123 | 12 | 36232890 |
| Pubmed | 1.21e-05 | 215 | 123 | 7 | 35973513 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 24424021 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 8524317 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 9632646 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19150855 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 8898078 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22253474 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 14550562 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19696509 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 21697367 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 32451822 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 1339456 | ||
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 1.24e-05 | 2 | 123 | 2 | 32473614 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19043076 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 9675099 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 1.24e-05 | 2 | 123 | 2 | 21531043 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 16678258 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 17496784 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 25404202 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 21969564 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 7530656 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 14985349 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22981886 | ||
| Pubmed | GTPBP4 IARS1 SMCHD1 GART RFC1 TRIP12 SART1 CSNK1D PREP AHNAK MDC1 MKI67 UBE2S LYN QARS1 XRCC6 | 1.42e-05 | 1297 | 123 | 16 | 33545068 | |
| Pubmed | Cdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitors. | 1.53e-05 | 14 | 123 | 3 | 20460369 | |
| Pubmed | Mutations in Eml1 lead to ectopic progenitors and neuronal heterotopia in mouse and human. | 1.53e-05 | 14 | 123 | 3 | 24859200 | |
| Pubmed | GTPBP4 IARS1 SMCHD1 GART SART1 USP5 PRPF3 PCNX4 MDC1 CCDC138 MKI67 XRCC6 | 1.58e-05 | 754 | 123 | 12 | 35906200 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.65e-05 | 313 | 123 | 8 | 38270169 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.77e-05 | 316 | 123 | 8 | 31665637 | |
| Pubmed | 1.90e-05 | 15 | 123 | 3 | 11440986 | ||
| Pubmed | 2.09e-05 | 234 | 123 | 7 | 36243803 | ||
| Pubmed | TRIP12 RYR2 SART1 GLI3 AHNAK MKI67 LRBA PARD3 SPEN RPL7 CUX1 NOL8 | 2.13e-05 | 777 | 123 | 12 | 35844135 | |
| Pubmed | GTPBP4 IARS1 GART RFC1 SART1 MKI67 ANKRD17 HELZ QARS1 RPL7 XRCC6 | 2.23e-05 | 655 | 123 | 11 | 35819319 | |
| Pubmed | 2.34e-05 | 16 | 123 | 3 | 32501282 | ||
| Interaction | MEN1 interactions | GTPBP4 ERCC6 WASHC4 IARS1 SMCHD1 RFC1 TRIP12 ATF2 ZFY SART1 PRPF3 NFKB1 MDC1 MKI67 ANKRD17 CPSF2 QARS1 SPEN CUX1 NOL8 | 2.41e-06 | 1029 | 119 | 20 | int:MEN1 |
| Interaction | CBX3 interactions | IKZF3 ATG7 SMCHD1 HMGXB4 RFC1 TRIP12 PCGF6 PRPF3 MDC1 MKI67 MASTL SPEN XRCC6 CUX1 NOL8 | 6.25e-06 | 646 | 119 | 15 | int:CBX3 |
| Interaction | BRD3 interactions | GTPBP4 SMCHD1 HMGXB4 RFC1 TRIP12 C2CD5 ZFY SLC4A1 ZNF711 SART1 PRPF3 MDC1 MKI67 | 7.23e-06 | 494 | 119 | 13 | int:BRD3 |
| Interaction | SIRT7 interactions | GTPBP4 SMCHD1 GART RFC1 TRIP12 SART1 USP5 PREP AHNAK MDC1 MKI67 ANKRD17 HELZ SPEN RPL7 XRCC6 | 7.88e-06 | 744 | 119 | 16 | int:SIRT7 |
| Interaction | XRCC6 interactions | IKZF3 RNF31 ATG7 SMCHD1 GART RFC1 TRIP12 SEPTIN2 ZNF711 SART1 PRPF3 MDC1 MKI67 UBE2S SPEN VAV1 XRCC6 NOL8 | 8.41e-06 | 928 | 119 | 18 | int:XRCC6 |
| Interaction | SUMO2 interactions | ERCC6 IARS1 SMCHD1 HMGXB4 TRIP12 ABCA8 SART1 USP5 AHNAK MDC1 MKI67 CPSF2 XRCC6 CUX1 | 1.04e-05 | 591 | 119 | 14 | int:SUMO2 |
| Interaction | KIF20A interactions | GTPBP4 PTBP2 IARS1 DPYSL5 ACTN2 ACTN3 SART1 CSNK1D AHNAK MDC1 MKI67 HELZ SSH2 CPSF2 PARD3 LYN RPL3L RPL7 XRCC6 | 1.26e-05 | 1052 | 119 | 19 | int:KIF20A |
| Interaction | USP53 interactions | 1.79e-05 | 138 | 119 | 7 | int:USP53 | |
| Interaction | ARL4D interactions | 2.58e-05 | 146 | 119 | 7 | int:ARL4D | |
| Interaction | SLX4 interactions | GTPBP4 ERCC6 NELFA SMCHD1 GART SART1 USP5 PRPF3 CSNK1E MDC1 MKI67 RPL7 NOL8 | 3.38e-05 | 572 | 119 | 13 | int:SLX4 |
| Interaction | CHD4 interactions | GTPBP4 IKZF3 ERCC6 HMGXB4 DPYSL5 RFC1 TRIP12 SART1 PCGF6 PRPF3 AHNAK MDC1 MKI67 CPSF2 SPEN RPL7 XRCC6 | 3.64e-05 | 938 | 119 | 17 | int:CHD4 |
| Interaction | H3C3 interactions | GTPBP4 PTBP2 SMCHD1 HMGXB4 RFC1 TRIP12 PCGF6 MDC1 MKI67 SPEN XRCC6 CUX1 | 3.71e-05 | 495 | 119 | 12 | int:H3C3 |
| Interaction | NOTCH1 interactions | 3.87e-05 | 345 | 119 | 10 | int:NOTCH1 | |
| Interaction | BRCA1 interactions | ERCC6 IARS1 SMCHD1 GART ACTN3 RFC1 ATF2 MAP3K1 SEPTIN2 JAK2 PRPF3 CSNK1D PREP AHNAK NFKB1 MDC1 MKI67 QARS1 RPL7 XRCC6 | 4.10e-05 | 1249 | 119 | 20 | int:BRCA1 |
| Interaction | OPTN interactions | RNF31 IARS1 SMCHD1 ZNF711 JAK2 USP5 CSNK1D MKI67 UBE2S QARS1 XRCC6 | 4.14e-05 | 422 | 119 | 11 | int:OPTN |
| Interaction | POU5F1 interactions | PTBP2 SMCHD1 RFC1 ATF2 SEPTIN2 USP42 PRPF3 AHNAK MDC1 ANKRD17 HELZ CPSF2 XRCC6 | 4.19e-05 | 584 | 119 | 13 | int:POU5F1 |
| Interaction | BRD2 interactions | GTPBP4 SMCHD1 HMGXB4 RFC1 C2CD5 SLC4A1 ZNF711 PRPF3 PCNX4 MDC1 LYN | 4.80e-05 | 429 | 119 | 11 | int:BRD2 |
| Interaction | PYHIN1 interactions | GTPBP4 ZNF711 PRPF3 MDC1 MKI67 ANKRD17 CPSF2 SPEN RPL7 XRCC6 | 5.28e-05 | 358 | 119 | 10 | int:PYHIN1 |
| Interaction | PRC1 interactions | GALNTL6 GTPBP4 NELFA DPYSL5 ACTN2 ACTN3 SART1 USP5 CNOT6L AHNAK MDC1 MKI67 QARS1 SPEN RPL3L RPL7 XRCC6 | 5.74e-05 | 973 | 119 | 17 | int:PRC1 |
| Interaction | PRPF3 interactions | 5.83e-05 | 291 | 119 | 9 | int:PRPF3 | |
| Interaction | NAA40 interactions | GTPBP4 STRN3 ATG7 SMCHD1 GART RFC1 SEPTIN2 PRPF3 AHNAK MKI67 MASTL ANKRD17 HELZ LRBA RPL7 XRCC6 NOL8 | 6.12e-05 | 978 | 119 | 17 | int:NAA40 |
| Interaction | CEP85 interactions | 6.56e-05 | 169 | 119 | 7 | int:CEP85 | |
| Interaction | ECT2 interactions | GTPBP4 IARS1 ACTN2 ACTN3 TRIP12 SEPTIN2 SART1 AHNAK MDC1 MKI67 CPSF2 PARD3 RPL3L RPL7 XRCC6 CUX1 | 6.66e-05 | 887 | 119 | 16 | int:ECT2 |
| Interaction | AR interactions | RNF31 NELFA IARS1 SMCHD1 DTX3L ACTN2 ATF2 SART1 USP5 PRPF3 GLI3 NFKB1 MDC1 LYN VAV1 XRCC6 CUX1 | 7.29e-05 | 992 | 119 | 17 | int:AR |
| Interaction | EPHA1 interactions | 7.83e-05 | 235 | 119 | 8 | int:EPHA1 | |
| Interaction | YY1 interactions | SMCHD1 HMGXB4 TRIP12 ATF2 SART1 PCGF6 CSNK1D NFKB1 MDC1 MKI67 XRCC6 | 7.97e-05 | 454 | 119 | 11 | int:YY1 |
| Interaction | CENPA interactions | GTPBP4 ERCC6 SMCHD1 HMGXB4 RFC1 TRIP12 ZNF711 XRCC6 CUX1 NOL8 | 8.12e-05 | 377 | 119 | 10 | int:CENPA |
| Interaction | IFI16 interactions | GTPBP4 SMCHD1 GART RFC1 TRIP12 SART1 PCGF6 PRPF3 MDC1 MKI67 HELZ QARS1 RPL7 XRCC6 | 8.23e-05 | 714 | 119 | 14 | int:IFI16 |
| Interaction | TERF2IP interactions | NELFA SMCHD1 HMGXB4 RFC1 TRIP12 SART1 MDC1 MKI67 MASTL SPEN XRCC6 CUX1 | 1.05e-04 | 552 | 119 | 12 | int:TERF2IP |
| Interaction | HOXC4 interactions | 1.09e-04 | 42 | 119 | 4 | int:HOXC4 | |
| Interaction | CIT interactions | GTPBP4 IARS1 SMCHD1 GART ACTN2 ACTN3 TRIP12 SLC1A3 SART1 PRPF3 AHNAK MDC1 MKI67 SSH2 CPSF2 PARD3 QARS1 RPL3L RPL7 XRCC6 CUX1 | 1.09e-04 | 1450 | 119 | 21 | int:CIT |
| Interaction | PML interactions | ERCC6 NELFA SMCHD1 HMGXB4 DTX3L ATF2 SEPTIN2 SART1 USP5 PRPF3 CSNK1D AHNAK NFKB1 MDC1 MASTL RPL7 | 1.20e-04 | 933 | 119 | 16 | int:PML |
| Interaction | FAM83D interactions | 1.25e-04 | 82 | 119 | 5 | int:FAM83D | |
| Interaction | CAPZB interactions | WASHC4 ATG7 NELFA IARS1 RTN4IP1 POLR3D CNOT6L CSNK1D NFKB1 MDC1 CCDC138 MKI67 ANKRD17 QARS1 TXN2 RPL7 XRCC6 | 1.43e-04 | 1049 | 119 | 17 | int:CAPZB |
| Interaction | H2BC3 interactions | 1.49e-04 | 406 | 119 | 10 | int:H2BC3 | |
| Interaction | ADARB1 interactions | GTPBP4 IARS1 RFC1 SEPTIN2 PRPF3 AHNAK MDC1 MKI67 RPL7 XRCC6 NOL8 | 1.53e-04 | 489 | 119 | 11 | int:ADARB1 |
| Interaction | CNOT7 interactions | 1.84e-04 | 140 | 119 | 6 | int:CNOT7 | |
| Interaction | TRMT1 interactions | 1.84e-04 | 140 | 119 | 6 | int:TRMT1 | |
| Interaction | NUPR1 interactions | GTPBP4 SMCHD1 GART TRIP12 SEPTIN2 SART1 PRPF3 AHNAK MDC1 MKI67 SSH2 LYN XRCC6 | 2.00e-04 | 683 | 119 | 13 | int:NUPR1 |
| Interaction | DBNDD1 interactions | 2.06e-04 | 4 | 119 | 2 | int:DBNDD1 | |
| Interaction | RBMY1E interactions | 2.06e-04 | 4 | 119 | 2 | int:RBMY1E | |
| Interaction | HECTD1 interactions | GTPBP4 ERCC6 SMCHD1 RFC1 TRIP12 MAP3K1 SART1 PRPF3 CSNK1E MKI67 SSH2 CPSF2 QARS1 RPL7 XRCC6 NOL8 | 2.20e-04 | 984 | 119 | 16 | int:HECTD1 |
| Interaction | PPIA interactions | STRN3 IKZF3 ERCC6 GART HMGXB4 RFC1 JAK2 PREP AHNAK ERRFI1 MKI67 MASTL CPSF2 XRCC6 CUX1 | 2.34e-04 | 888 | 119 | 15 | int:PPIA |
| Interaction | RPL39 interactions | 2.58e-04 | 149 | 119 | 6 | int:RPL39 | |
| Interaction | NCL interactions | GTPBP4 IKZF3 ERCC6 WASHC4 RNF31 RFC1 RYR2 SART1 PRPF3 MDC1 UBE2S CPSF2 RPL7 XRCC6 | 2.61e-04 | 798 | 119 | 14 | int:NCL |
| Interaction | UBE2E2 interactions | 2.63e-04 | 96 | 119 | 5 | int:UBE2E2 | |
| Interaction | H3C1 interactions | GTPBP4 ERCC6 SMCHD1 HMGXB4 RFC1 TRIP12 ZNF711 PCGF6 PRPF3 AHNAK MDC1 MKI67 SPEN XRCC6 CUX1 | 2.74e-04 | 901 | 119 | 15 | int:H3C1 |
| Interaction | SAV1 interactions | 2.77e-04 | 151 | 119 | 6 | int:SAV1 | |
| Interaction | ELF3 interactions | 2.91e-04 | 54 | 119 | 4 | int:ELF3 | |
| Interaction | MCC interactions | 2.91e-04 | 215 | 119 | 7 | int:MCC | |
| Interaction | ZNF330 interactions | GTPBP4 SMCHD1 HMGXB4 PBX4 RFC1 TRIP12 ZNF711 XRCC6 CUX1 NOL8 | 3.16e-04 | 446 | 119 | 10 | int:ZNF330 |
| Interaction | PRIM1 interactions | 3.81e-04 | 104 | 119 | 5 | int:PRIM1 | |
| Interaction | CCNT1 interactions | 3.83e-04 | 225 | 119 | 7 | int:CCNT1 | |
| Interaction | LDLRAD4 interactions | 4.09e-04 | 59 | 119 | 4 | int:LDLRAD4 | |
| Cytoband | Yq11.223 | 5.47e-06 | 93 | 123 | 5 | Yq11.223 | |
| GeneFamily | RNA binding motif containing | 7.00e-07 | 213 | 85 | 9 | 725 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 6.53e-05 | 3 | 85 | 2 | 287 | |
| GeneFamily | Actinins | 1.30e-04 | 4 | 85 | 2 | 1112 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STRN3 WASHC4 SMCHD1 HMGXB4 TRIP12 ATF2 C2CD2 C2CD5 SERPINE1 ANKRD17 HELZ PARD3 LYN SPEN CUX1 | 3.85e-09 | 466 | 120 | 15 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STRN3 WASHC4 SMCHD1 HMGXB4 PSD3 TRIP12 ATF2 C2CD2 C2CD5 RIN2 NFKB1 SERPINE1 MTR ANKRD17 HELZ PARD3 LYN SPEN CUX1 | 1.25e-08 | 856 | 120 | 19 | M4500 |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 3.96e-07 | 33 | 120 | 5 | MM701 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 1.95e-06 | 45 | 120 | 5 | MM763 | |
| Coexpression | GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP | 4.04e-06 | 200 | 120 | 8 | M6480 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ERCC6 RTN4IP1 MAGEB16 PCGF6 ZNF600 PRPF3 SNX25 MDC1 CCDC138 MASTL MTR HELZ SSH2 LRBA XRCC6 NOL8 S100PBP | 3.25e-06 | 820 | 119 | 17 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | GTPBP4 NELFA RBMY1A1 RTN4IP1 MAGEB16 C2CD5 PCGF6 ZNF600 CCDC138 MASTL MTR UBE2S HELZ XRCC6 NOL8 | 3.15e-05 | 781 | 119 | 15 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.23e-07 | 189 | 120 | 7 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-07 | 191 | 120 | 7 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.83e-07 | 191 | 120 | 7 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-07 | 191 | 120 | 7 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 9.15e-07 | 192 | 120 | 7 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.47e-07 | 193 | 120 | 7 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 1.05e-06 | 196 | 120 | 7 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 3.45e-06 | 151 | 120 | 6 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.17e-06 | 162 | 120 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 6.81e-06 | 170 | 120 | 6 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 7.53e-06 | 173 | 120 | 6 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 9.44e-06 | 180 | 120 | 6 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | Control-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 9.44e-06 | 180 | 120 | 6 | 47036eee4c128fbb443d1fc767b4de5cced93f0e | |
| ToppCell | COVID-19-T_cells-Tregs|COVID-19 / group, cell type (main and fine annotations) | 9.75e-06 | 181 | 120 | 6 | 534659cf754326c6a73c0daa30e9d610612a0292 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 9.75e-06 | 181 | 120 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 185 | 120 | 6 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 185 | 120 | 6 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.10e-05 | 185 | 120 | 6 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-05 | 186 | 120 | 6 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.17e-05 | 187 | 120 | 6 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 188 | 120 | 6 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-05 | 189 | 120 | 6 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 190 | 120 | 6 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-05 | 190 | 120 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 190 | 120 | 6 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 190 | 120 | 6 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 1.28e-05 | 190 | 120 | 6 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 1.28e-05 | 190 | 120 | 6 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 190 | 120 | 6 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 1.28e-05 | 190 | 120 | 6 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 190 | 120 | 6 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 190 | 120 | 6 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 190 | 120 | 6 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 190 | 120 | 6 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.32e-05 | 191 | 120 | 6 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 1.36e-05 | 192 | 120 | 6 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 192 | 120 | 6 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.36e-05 | 192 | 120 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4|Lung / Manually curated celltypes from each tissue | 1.36e-05 | 192 | 120 | 6 | fd19cd0b5330448bef8debd753285adbc8b958a2 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 1.36e-05 | 192 | 120 | 6 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.36e-05 | 192 | 120 | 6 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.36e-05 | 192 | 120 | 6 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 192 | 120 | 6 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 1.40e-05 | 193 | 120 | 6 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 193 | 120 | 6 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 1.40e-05 | 193 | 120 | 6 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 193 | 120 | 6 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 1.40e-05 | 193 | 120 | 6 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 193 | 120 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 193 | 120 | 6 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 1.44e-05 | 194 | 120 | 6 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-05 | 195 | 120 | 6 | 5650975e98dacf4333373c8c04aff0a0944acc7c | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.53e-05 | 196 | 120 | 6 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.58e-05 | 197 | 120 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.58e-05 | 197 | 120 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 198 | 120 | 6 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 1.72e-05 | 200 | 120 | 6 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.72e-05 | 200 | 120 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | H1299|World / Cell line, Condition and Strain | 1.72e-05 | 200 | 120 | 6 | 23f08d7cffacfced48785cd3ad230ecadb95713f | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 75 | 120 | 4 | 7f3be37cc378ee115fcb4b0eb9653fc77447aa0a | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-05 | 163 | 120 | 5 | 924c666596bbb42d7876c9b164a725277f3efa5f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.96e-05 | 167 | 120 | 5 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 9.48e-05 | 169 | 120 | 5 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 9.48e-05 | 169 | 120 | 5 | 29db25e7c5f31d98a08a35d7ec5ade203242bc50 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-05 | 169 | 120 | 5 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 9.48e-05 | 169 | 120 | 5 | b1611e61f635f8f9b87250e026ad30999cbee041 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.00e-04 | 171 | 120 | 5 | e1fe07652c10c37191d1471ddaea500f74269e0c | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.00e-04 | 171 | 120 | 5 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 172 | 120 | 5 | 55fba5ce0ead1114e1a76f67ad68432c6bac90e5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 173 | 120 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.09e-04 | 174 | 120 | 5 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 174 | 120 | 5 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 174 | 120 | 5 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 176 | 120 | 5 | 91ad2c34144f72283ca112fd3b3784f2f6259f65 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 178 | 120 | 5 | af9bcee71fb44a6342d4b92bba5b8ddfeeaa24b2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 178 | 120 | 5 | 69f68eeab11b088fcb1f963c92eff0f1cd0e711a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 178 | 120 | 5 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 178 | 120 | 5 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 179 | 120 | 5 | f4fd214a9865c635d8a744ce5e0eff45174d3de4 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 179 | 120 | 5 | 57d8d44a793314eec8f77030f4177bfe21d41652 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 180 | 120 | 5 | cea62fc006d68c3815c88bf17ec2617d7e41c3d2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 181 | 120 | 5 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 181 | 120 | 5 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 181 | 120 | 5 | 0c3f469bed108994ed696230e3c30343f7a301d3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 182 | 120 | 5 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 182 | 120 | 5 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Control / Disease state, Lineage and Cell class | 1.34e-04 | 182 | 120 | 5 | 31bb838cc2900f3c9da9f835d79d557a08abb928 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 1.34e-04 | 182 | 120 | 5 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 182 | 120 | 5 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 182 | 120 | 5 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 182 | 120 | 5 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 182 | 120 | 5 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 182 | 120 | 5 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.41e-04 | 184 | 120 | 5 | 2c286712428662bc4589dc5ac4011bf7ed403cb5 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|IPF / Disease state, Lineage and Cell class | 1.45e-04 | 185 | 120 | 5 | 221cbd09d94cc0947d0e3c1aa14716d17cb2068d | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-04 | 185 | 120 | 5 | a86a3a1a187a4d8d7762bc6d3dcb22c982178d22 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 1.45e-04 | 185 | 120 | 5 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 1.45e-04 | 185 | 120 | 5 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 185 | 120 | 5 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 186 | 120 | 5 | 41e03be964044dae690d566bd078dab3d8045eba | |
| Computational | tRNA synthesis. | 1.45e-04 | 15 | 76 | 3 | MODULE_160 | |
| Computational | Genes in the cancer module 110. | 1.78e-04 | 16 | 76 | 3 | MODULE_110 | |
| Computational | Genes in the cancer module 35. | 1.78e-04 | 16 | 76 | 3 | MODULE_35 | |
| Computational | Response to DNA damage. | 3.42e-04 | 187 | 76 | 7 | MODULE_244 | |
| Drug | 2-chlorodideoxyadenosine | 3.07e-06 | 43 | 120 | 5 | CID000072194 | |
| Drug | hydantoin-5-propionic acid | 4.10e-06 | 21 | 120 | 4 | CID000000782 | |
| Drug | HgCl | 5.92e-06 | 49 | 120 | 5 | CID000024182 | |
| Drug | AZFd | 6.01e-06 | 23 | 120 | 4 | CID000196489 | |
| Drug | azafagomine | 1.26e-05 | 57 | 120 | 5 | CID011957435 | |
| Drug | diisopropylphosphate | 1.81e-05 | 30 | 120 | 4 | CID000074162 | |
| Disease | lung cancer (is_marker_for) | 1.46e-05 | 39 | 112 | 4 | DOID:1324 (is_marker_for) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 4.27e-05 | 3 | 112 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 4.27e-05 | 3 | 112 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Cerebellar Hemiataxia | 8.53e-05 | 4 | 112 | 2 | C0750994 | |
| Disease | Cerebellar Dysmetria | 8.53e-05 | 4 | 112 | 2 | C0234162 | |
| Disease | Hypermetria (finding) | 8.53e-05 | 4 | 112 | 2 | C3668822 | |
| Disease | Adiadochokinesis | 8.53e-05 | 4 | 112 | 2 | C0234357 | |
| Disease | lung carcinoma (is_marker_for) | 1.42e-04 | 5 | 112 | 2 | DOID:3905 (is_marker_for) | |
| Disease | Cerebellar Ataxia | 1.42e-04 | 5 | 112 | 2 | C0007758 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.42e-04 | 5 | 112 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Hereditary, Type VII, Motor and Sensory Neuropathy | 2.12e-04 | 6 | 112 | 2 | C0019816 | |
| Disease | Hereditary Motor and Sensory Neuropathies | 2.12e-04 | 6 | 112 | 2 | C0027888 | |
| Disease | Malignant neoplasm of breast | ERCC6 GRIK2 DTX3L ATF2 SLC2A2 MAP3K1 CSNK1D P3H2 MKI67 MTR LRBA SPEN CUX1 | 2.22e-04 | 1074 | 112 | 13 | C0006142 |
| Disease | eosinophil percentage of granulocytes | 2.77e-04 | 234 | 112 | 6 | EFO_0007996 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 2.96e-04 | 7 | 112 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | Dejerine-Sottas Disease (disorder) | 2.96e-04 | 7 | 112 | 2 | C0011195 | |
| Disease | Polysyndactyly | 2.96e-04 | 7 | 112 | 2 | C0265553 | |
| Disease | hippocampal CA3 volume | 3.47e-04 | 36 | 112 | 3 | EFO_0009395 | |
| Disease | insulinoma (is_marker_for) | 3.94e-04 | 8 | 112 | 2 | DOID:3892 (is_marker_for) | |
| Disease | helix rolling | 3.94e-04 | 8 | 112 | 2 | EFO_0007670 | |
| Disease | Hematological Disease | 3.94e-04 | 8 | 112 | 2 | C0018939 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 5.88e-04 | 43 | 112 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | macrophage migration inhibitory factor measurement | 5.88e-04 | 43 | 112 | 3 | EFO_0008221 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 6.30e-04 | 10 | 112 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 7.78e-04 | 108 | 112 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | late-onset Alzheimers disease | 8.88e-04 | 292 | 112 | 6 | EFO_1001870 | |
| Disease | outer ear morphology trait | 9.19e-04 | 12 | 112 | 2 | EFO_0007664 | |
| Disease | ADHD symptom measurement | 9.19e-04 | 12 | 112 | 2 | EFO_0007860 | |
| Disease | R-6-hydroxywarfarin measurement | 9.52e-04 | 114 | 112 | 4 | EFO_0803327 | |
| Disease | Common variable immunodeficiency | 1.08e-03 | 13 | 112 | 2 | cv:C0009447 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.08e-03 | 13 | 112 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | unipolar depression, mood disorder, response to antidepressant | 1.26e-03 | 14 | 112 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | anemia (implicated_via_orthology) | 1.45e-03 | 15 | 112 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | thrombosis (is_implicated_in) | 1.45e-03 | 15 | 112 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | endometriosis (biomarker_via_orthology) | 1.65e-03 | 16 | 112 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | ovarian neoplasm | 1.73e-03 | 134 | 112 | 4 | C0919267 | |
| Disease | cortical surface area measurement | STRN3 DCDC1 DPYSL5 MAP3K1 PCGF6 GLI3 NFKB1 MDC1 SSH2 PARD3 QARS1 XRCC6 CUX1 | 1.78e-03 | 1345 | 112 | 13 | EFO_0010736 |
| Disease | neutrophil percentage of granulocytes | 1.81e-03 | 228 | 112 | 5 | EFO_0007994 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 1.87e-03 | 64 | 112 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of ovary | 1.87e-03 | 137 | 112 | 4 | C1140680 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.98e-03 | 139 | 112 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | stomach cancer (is_marker_for) | 2.14e-03 | 142 | 112 | 4 | DOID:10534 (is_marker_for) | |
| Disease | platelet component distribution width | 2.37e-03 | 755 | 112 | 9 | EFO_0007984 | |
| Disease | attention function measurement | 2.48e-03 | 148 | 112 | 4 | EFO_0007636 | |
| Disease | renal system measurement | 2.59e-03 | 20 | 112 | 2 | EFO_0004742 | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.59e-03 | 20 | 112 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 2.62e-03 | 72 | 112 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | Colonic Neoplasms | 2.73e-03 | 152 | 112 | 4 | C0009375 | |
| Disease | Malignant tumor of colon | 3.21e-03 | 159 | 112 | 4 | C0007102 | |
| Disease | non-melanoma skin carcinoma | 3.46e-03 | 265 | 112 | 5 | EFO_0009260 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GDKMTKTGSHPKLDR | 231 | Q8N129 | |
| KPDRGKMRFHKIANV | 86 | P35609 | |
| KHKGKPTFMEEVLEH | 181 | Q8NEF3 | |
| KGKLCPFRHDRGEKM | 51 | A6NMK7 | |
| FGGKDIKVYMPKLHE | 581 | Q9P2I0 | |
| KPERKMVKGSGFHLD | 691 | P02730 | |
| VRGKEPFHKMKQFLS | 601 | P39880 | |
| TKRAGMKELKRHPLF | 821 | Q96GX5 | |
| KGEADRHVFDMKPKH | 606 | Q9BZE4 | |
| LESGDHGKIKFPTMK | 296 | Q09666 | |
| VDLHMKGPKVKGEYD | 951 | Q09666 | |
| LHLKGPKVKGDMDVS | 1996 | Q09666 | |
| KHKHEMTLKFGPARN | 46 | P15336 | |
| THKLAEMRVKAAPKG | 171 | A0A0U1RR37 | |
| KITPLMAAFRKGHVK | 1386 | O75179 | |
| GIMKKEGKDNVPEHF | 1356 | Q03468 | |
| KMKEKRVLLSADGPH | 391 | Q8TBG4 | |
| KGEKRASELAKHPMV | 261 | Q6P387 | |
| REIGGFKMPKDKVDS | 411 | Q9H095 | |
| LPHKASGFLMKKELD | 181 | P07205 | |
| EKMLKAVFGKHGPIS | 21 | P0DJD3 | |
| EKMLKAVFGKHGPIS | 21 | A6NDE4 | |
| EKMLKAVFGKHGPIS | 21 | P0DJD4 | |
| EKMLKAVFGKHGPIS | 21 | P0C7P1 | |
| EKMLKAVFGKHGPIS | 21 | A6NEQ0 | |
| EKMLKAVFGKHGPIS | 21 | Q15415 | |
| HGPISMDFAISKLKK | 401 | O60674 | |
| DRFLSKMKVQPKHLG | 81 | P51959 | |
| EISHKPGMKAGRINK | 1136 | Q8N7Z5 | |
| VSMGHGFKTPKELKQ | 1731 | M0R2J8 | |
| TGDPMHNKRSKIKPD | 426 | P10071 | |
| PMKKRKIFHGVGTRG | 346 | Q14676 | |
| SGKKHFIFGEPRMLI | 236 | A2A368 | |
| PFHAKGRGLLRKMDT | 196 | Q9H3P2 | |
| RKDGGKVFMKRPDPH | 2596 | Q9UKN7 | |
| MAAWGKKHAGKDPVR | 1 | Q8IZU0 | |
| DMGHKIGTKSKDLPS | 331 | Q63HM2 | |
| HRDVKPDNFLMGLGK | 126 | P48730 | |
| KKSGSAHRPKAAVEM | 501 | P11168 | |
| AHRPKAAVEMKFLGA | 506 | P11168 | |
| APKRKAEVMLGHGLF | 751 | P50851 | |
| HRDGKVFMPGNKVLL | 461 | Q8N4P6 | |
| GKAMHTPKAAVGEEK | 1901 | P46013 | |
| LEDGGSHKSKKMKPL | 161 | Q9UGU5 | |
| PMSKKRRGEFSDFHG | 201 | Q76FK4 | |
| EVHGFSMGKKLSPKI | 421 | Q8IVL5 | |
| PRGGMKKKTTHFVEG | 216 | P18124 | |
| YEGKLMASGKQPAHK | 881 | P42694 | |
| PMFIVHKKGIKLDGS | 451 | P48147 | |
| PKEIERMVGAIHGKF | 171 | Q9BYU1 | |
| GFDTFVVMRHGLKKP | 501 | O95352 | |
| MSVLEPGTAKKHKGG | 611 | Q9Y426 | |
| SKVKHEESGMDGKKP | 371 | Q96M89 | |
| KKHLMRRGEASPKAP | 96 | Q8IXT2 | |
| AGKKLKEGHETPMDI | 516 | Q8TDB6 | |
| HPGKGTKENMHREGK | 146 | P43003 | |
| KGKRPKDTFNKMAHR | 11 | P0C843 | |
| MKKHVAGTKGPHSEL | 876 | Q8N1P7 | |
| GIHPDDLSFKKGEKM | 76 | P07948 | |
| GTPGDLSKRKMLVHF | 21 | A6NGU7 | |
| AKPLLKEMKRGKEFH | 211 | Q13002 | |
| RKSSMPQKFIGEKRH | 266 | Q9UKT9 | |
| MFHKYTGRDGKIEKP | 16 | Q86SG5 | |
| GKMKGHERRLGKVIP | 286 | Q96BU1 | |
| KKMELESKGGGNHPL | 2856 | Q92736 | |
| LDSEKHKKGPMETGL | 176 | Q9H825 | |
| MPGKLKVKIVAGRHL | 1 | Q86YS7 | |
| HRPFTTKQKAMGKED | 326 | Q9BPU6 | |
| GMDKKKAADHLKPFL | 41 | O43395 | |
| GGPKAQKKFKRLMLH | 586 | O43395 | |
| GHVEKFLRRKMGLDP | 286 | Q9BYE7 | |
| GDMFRFGKHRKDDKI | 1021 | Q8TEW0 | |
| GFKIDDKGMAPALRH | 86 | P05121 | |
| NKETLKGLHKMDDRP | 166 | Q13233 | |
| QKEAMRSGKGEHGKP | 76 | Q49A17 | |
| MKRDPLHVKIKGEEF | 101 | Q8WWV3 | |
| KEVMLFGHGTRKRVP | 331 | Q9HA92 | |
| MEQLRGEALKFHKPG | 221 | P47897 | |
| DMGPSHIINIKKEKR | 131 | P05423 | |
| IEGIPEGKDKHRMNK | 266 | Q13033 | |
| KRHGAKGMDTPAFEL | 86 | P49590 | |
| DEPKHLKCEMKGGKT | 1146 | A6NHR9 | |
| KFKGEDKMDGAPSRV | 46 | Q9UKA9 | |
| RAFMGPQKKHLEKET | 386 | Q92901 | |
| DSHRAKKDIKMGPFD | 836 | P35251 | |
| HVKPVAAGGDMKKHL | 891 | P35251 | |
| FPQLKRHKGKETAAM | 216 | Q9H3E2 | |
| KKAVGHLIPFMEKER | 741 | Q99707 | |
| PDHMVLGKRLKGAFK | 896 | P41252 | |
| VGKKQSDPHLMDKHG | 241 | Q2Y0W8 | |
| TEKPDSKTKMDLGGH | 436 | Q9UJM3 | |
| HLKFLLGHGMPAKKE | 136 | O94911 | |
| LPRPDKGKMRFHKIA | 91 | Q08043 | |
| MPFLEAAGHKLGAKK | 366 | Q9Y4C5 | |
| QKEAGKFGTHRGKPM | 46 | G3V211 | |
| VLEVHKELFGAGMKP | 331 | Q96LI5 | |
| LGPRLEKMVAKQHGK | 96 | Q99757 | |
| FHKKLTEGVLMRDPK | 781 | Q96EP0 | |
| KPLKGHVEAMLKDFH | 601 | Q8WYP3 | |
| DLMHLKKPGGFDISL | 201 | P12956 | |
| EGVGPFREKTKHLRM | 1286 | Q9H9J4 | |
| MLHEEAAQKRKGKEP | 1 | Q96N58 | |
| RMKVPKEKGLSSHVE | 936 | Q96T58 | |
| HSFVLKEPEMSKGKG | 921 | Q76I76 | |
| GKLMKEKGQHLEPFI | 711 | Q9Y5W7 | |
| DIMSDLFGLHPKKEG | 4276 | Q15413 | |
| RHGQDFPGTMKKDKL | 566 | P15498 | |
| FPGTMKKDKLHRRAQ | 571 | P15498 | |
| PFMRKGAVGDWKKHF | 261 | O75897 | |
| AMKKFLGELHDFIPG | 181 | Q8NHR7 | |
| VPLGDSKSHRMKKDP | 516 | A0A0J9YWL9 | |
| MGSSKKHRGEKEAAG | 1 | O43290 | |
| GGTKFLKNMDKGHPI | 911 | Q9NRE2 | |
| SKRFAKEFMDRHGIP | 106 | P22102 | |
| AEGPMAKKHAGERDK | 191 | Q16763 | |
| LEQGKKPFTVKRHEM | 56 | Q03938 | |
| HLKLDDRNPFKVGMK | 691 | Q2M389 | |
| FGHGLKPLDVAFMKA | 156 | Q15019 | |
| KASPHGGKKAREVGM | 636 | Q5JPB2 | |
| GKGFRHPSELKKHMR | 511 | Q9Y462 | |
| FGRTAKPAHIAKVKM | 1681 | Q14669 | |
| DERNGHEAPMTKIKK | 51 | Q6ZNG1 | |
| IHADMDGKKTPRGKR | 796 | Q9NYI0 | |
| MFKALIGKGHPEFST | 416 | P45974 | |
| ERNGHEAPMTKIKKL | 121 | Q0VGE8 | |
| EMCEKGFHRPSELKK | 661 | P08048 | |
| HRDVKPDNFLMGLGK | 126 | P49674 | |
| LYRHKKSKFTDPGMG | 1746 | O75096 | |
| AMEKGKLHKPGKDAS | 196 | P25189 | |
| KHGTMDTESKKDPEG | 431 | P19838 |